| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |